Catalyst Wire Dossier Catalyst Wire Dossier

VELPHORO

sucroferric oxyhydroxide · Fresenius Medical Care Renal Therapies Group, LLC
Drug timelines are a Plus or Pro feature.

11 regulatory and trial events tracked for VELPHORO, covering 2013-11-27 to 2026-03-24. Get the full timeline:

Most recent: EMA Authorised: Velphoro (sucroferric oxyhydroxide) — Vifor Fresenius Medical Care Renal Pharma France

See pricing